Pharma Equity Group A/S (CHIX:PEGC) Ending Cash Position : kr4.23 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharma Equity Group A/S Ending Cash Position?

Pharma Equity Group A/S's Ending Cash Position for the quarter that ended in Dec. 2023 was kr4.23 Mil.

Pharma Equity Group A/S's quarterly Ending Cash Position declined from Jun. 2023 (kr3.51 Mil) to Sep. 2023 (kr1.48 Mil) but then increased from Sep. 2023 (kr1.48 Mil) to Dec. 2023 (kr4.23 Mil).

Pharma Equity Group A/S's annual Ending Cash Position increased from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.18 Mil) and increased from Dec. 2022 (kr0.18 Mil) to Dec. 2023 (kr4.23 Mil).

Pharma Equity Group A/S Ending Cash Position Historical Data

The historical data trend for Pharma Equity Group A/S's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Ending Cash Position Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.18

4.23

Pharma Equity Group A/S Quarterly Data
	Mar16	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															-	12.08	3.51	1.48	4.23

Pharma Equity Group A/S Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pharma Equity Group A/S's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.868	+	0.363
	=	4.23

Pharma Equity Group A/S's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.476	+	2.755
	=	4.23

Pharma Equity Group A/S Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (CHIX:PEGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (CHIX:PEGc) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PEG:Denmark

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.

Pharma Equity Group A/S (CHIX:PEGC) Headlines

No Headlines